Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Diabetes in HFE Hemochromatosis.

Barton JC, Acton RT.

J Diabetes Res. 2017;2017:9826930. doi: 10.1155/2017/9826930. Epub 2017 Feb 26. Review.

2.

HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.

Warne CD, Zaloumis SG, Bertalli NA, Delatycki MB, Nicoll AJ, McLaren CE, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Allen KJ, Gurrin LC; HealthIron Study Investigators..

J Gastroenterol Hepatol. 2017 Apr;32(4):797-802. doi: 10.1111/jgh.13621.

PMID:
27784128
3.

Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.

Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL.

Radiology. 2016 Jan;278(1):114-24. doi: 10.1148/radiol.2015142141. Epub 2015 Jul 8.

4.

Haptoglobin duplicon, hemoglobin, and vitamin C: analyses in the british women's heart and health study and Caerphilly prospective study.

Guthrie PA, Abdollahi MR, Gaunt T, Lawlor DA, Ben-Shlomo Y, Gallacher J, Davey Smith G, Day IN, Rodriguez S.

Dis Markers. 2014;2014:529456. doi: 10.1155/2014/529456. Epub 2014 Nov 30.

5.

Evidence for the Influence of the Iron Regulatory MHC Class I Molecule HFE on Tumor Progression in Experimental Models and Clinical Populations.

Weston C, Connor J.

Transl Oncogenomics. 2014 Dec 4;6:1-12. doi: 10.4137/TOG.S19064. eCollection 2014. Review.

6.

Gender specific medicine in liver diseases: a point of view.

Durazzo M, Belci P, Collo A, Prandi V, Pistone E, Martorana M, Gambino R, Bo S.

World J Gastroenterol. 2014 Mar 7;20(9):2127-35. doi: 10.3748/wjg.v20.i9.2127. Review.

7.

Iron and diabetes risk.

Simcox JA, McClain DA.

Cell Metab. 2013 Mar 5;17(3):329-41. doi: 10.1016/j.cmet.2013.02.007. Review.

8.

Hereditary hemochromatosis: a literature review and case report.

Allen MK.

Physiother Can. 2010 Summer;62(3):276-84. doi: 10.3138/physio.62.3.276. Epub 2010 Jul 23.

9.

Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.

Alvarez-Blasco F, Martínez-García MA, Luque-Ramírez M, Parraza N, San Millán JL, Escobar-Morreale HF.

PLoS One. 2009;4(5):e5606. doi: 10.1371/journal.pone.0005606. Epub 2009 May 19.

10.

Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2.

Pelucchi S, Mariani R, Trombini P, Coletti S, Pozzi M, Paolini V, Barisani D, Piperno A.

Haematologica. 2009 Feb;94(2):276-9. doi: 10.3324/haematol.13576. Epub 2009 Jan 14.

11.

The myths and realities of hemochromatosis.

Beaton MD, Adams PC.

Can J Gastroenterol. 2007 Feb;21(2):101-4. Review.

12.

Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, Dawkins FW, McLaren CE, Reboussin DM.

Blood Cells Mol Dis. 2007 May-Jun;38(3):247-52. Epub 2007 Feb 5.

13.

Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.

Scotet V, Le Gac G, Mérour MC, Mercier AY, Chanu B, Ka C, Mura C, Nousbaum JB, Férec C.

BMC Med Genet. 2005 Jun 1;6:24.

14.

Hemochromatosis. More common than you think.

Borgaonkar MR.

Can Fam Physician. 2003 Jan;49:36-43. Review.

15.

Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?

Ryan E, Byrnes V, Coughlan B, Flanagan AM, Barrett S, O'Keane JC, Crowe J.

Gut. 2002 Jul;51(1):108-12.

Supplemental Content

Support Center